| 特利加压素治疗肝肾综合征的循证医学依据 |
| |
| 引用本文： | 张晶巧,吴云海,祁兴顺. 特利加压素治疗肝肾综合征的循证医学依据[J]. 世界华人消化杂志, 2019, 27(1): 1-5 |
| |
| 作者姓名： | 张晶巧 吴云海 祁兴顺 |
| |
| 作者单位： | 沈阳药科大学 辽宁省沈阳市110016;沈阳市第六人民医院重症监护病房 辽宁省沈阳市110006;北部战区总医院消化内科 辽宁省沈阳市110016 |
| |
| 摘 要： | 肝肾综合征(hepatorenal syndrome, HRS)是肝硬化的严重并发症之一,主要表现为少尿、尿钠潴留和血清肌酐升高.肝移植是治疗肝肾综合征的最佳方式,但仅有少部分患者进行了肝移植.目前药物治疗方式主要为血管收缩剂联合白蛋白.特利加压素是一种人工合成的血管加压素类似物,主要用于治疗肝肾综合征.本文旨在从循证医学角度回顾特利加压素治疗HRS的当前现状.
|
| 关 键 词： | 特利加压素 肝肾综合征 肝硬化 去甲肾上腺素 临床试验 |
Current evidence regarding terlipressin for treatment of hepatorenal syndrome |
| |
| Jing-Qiao Zhang,Yun-Hai Wu,Xing-Shun Qi. Current evidence regarding terlipressin for treatment of hepatorenal syndrome[J]. World Chinese Journal of Digestology, 2019, 27(1): 1-5 |
| |
| Authors: | Jing-Qiao Zhang Yun-Hai Wu Xing-Shun Qi |
| |
| Affiliation: | (Shenyang Pharmaceutical University,Shenyang 110016,Liaoning Province,China;Intensive Care Unit,the Sixth Hospital of Shenyang,Shenyang 110006,Liaoning Province,China;Department of Gastroenterology,General Hospital of Northern Theater Command (formerly General Hospital of Shenyang Military Area),Shenyang 110016,Liaoning Province,China) |
| |
| Abstract: | Jing-Qiao Zhang;Yun-Hai Wu;Xing-Shun Qi(Shenyang Pharmaceutical University,Shenyang 110016,Liaoning Province,China;Intensive Care Unit,the Sixth Hospital of Shenyang,Shenyang 110006,Liaoning Province,China;Department of Gastroenterology,General Hospital of Northern Theater Command (formerly General Hospital of Shenyang Military Area),Shenyang 110016,Liaoning Province,China) |
| |
| Keywords: | Terlipressin Hepatorenal syndrome Liver cirrhosis Noradrenaline Clinical trial |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
